A shadow economy for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.
Investigational Treatment Acquiring Popularity Via Social Media
Retatrutide, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are urged to message these profiles directly for source information, while also receiving discount codes.
Active Trade on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with numerous of participants share “before and after” photos, administration instructions and claims of rapid UK delivery. Vendors market the drug there before directing buyers to other platforms for purchases.
Learning About Retatrutide
Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.
Healthcare Experts Express Concerns
Nevertheless, doctors and pharmacists have warned that the distribution of what is still an unapproved medication in the UK is a cause for concern and could result in individuals injecting products of unknown origin.
Several experts stated the demand for the experimental drug could be linked to the rising cost of licensed weight loss treatments such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Several influencers try to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, risking penalties, prosecution or imprisonment.
Platform Reaction and Material Removal
According to TikTok, the service has removed violative material and prohibited related keywords and query recommendations. The organization said it was dedicated to keeping the platform safe and investing in strengthening compliance measures.
Digital Trading Activities
Investigations also found communities with up to 9,000 participants selling retatrutide using the platform's integrated search feature, which operates like a public directory. Typing “retatrutide” instantly brings up channels with thousands of users, filled with images of weight loss, positive reviews and detailed guides for preparing or injecting at home.
After moments of joining one community, a vendor posted contact information, where the majority of purchases take place. The vendor provided an instruction manual and promised shipping within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, health issues or previous experience.
Product Information and Costs
Within these communities, posts display black plastic packages with postal service labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled injectors typically priced at £160 for 20mg. When asked how long a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.
Platform Oversight and Safety Actions
A representative for the messaging service stated it regularly monitored harmful content on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are administering substances they cannot confirm. Although the research behind retatrutide is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in interest to current cost increases for authorized slimming medications such as Mounjaro. “With prices rising, patients are turning to social media. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.
Her team has previously seen patients injured by personal administration from unverified sources. “We recognize the disappointment, but buying from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may subject patients to possibly serious health risks”.
